nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CYP3A4—Esomeprazole—Barrett's esophagus	0.183	0.286	CbGbCtD
Fesoterodine—ABCB1—Omeprazole—Barrett's esophagus	0.18	0.281	CbGbCtD
Fesoterodine—CYP2D6—Omeprazole—Barrett's esophagus	0.17	0.265	CbGbCtD
Fesoterodine—CYP3A4—Omeprazole—Barrett's esophagus	0.108	0.168	CbGbCtD
Fesoterodine—Irritable bowel syndrome—Esomeprazole—Barrett's esophagus	0.0212	0.0645	CcSEcCtD
Fesoterodine—Irritable bowel syndrome—Omeprazole—Barrett's esophagus	0.0212	0.0645	CcSEcCtD
Fesoterodine—Functional gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.0198	0.0602	CcSEcCtD
Fesoterodine—Functional gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.0198	0.0602	CcSEcCtD
Fesoterodine—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—ATP4A—Barrett's esophagus	0.00615	0.209	CbGpPWpGaD
Fesoterodine—Gastrooesophageal reflux disease—Omeprazole—Barrett's esophagus	0.00553	0.0168	CcSEcCtD
Fesoterodine—Gastrooesophageal reflux disease—Esomeprazole—Barrett's esophagus	0.00553	0.0168	CcSEcCtD
Fesoterodine—Hepatic enzyme increased—Omeprazole—Barrett's esophagus	0.00528	0.0161	CcSEcCtD
Fesoterodine—Hepatic enzyme increased—Esomeprazole—Barrett's esophagus	0.00528	0.0161	CcSEcCtD
Fesoterodine—CHRM1—Secretion of Hydrochloric Acid in Parietal Cells—GAST—Barrett's esophagus	0.00491	0.167	CbGpPWpGaD
Fesoterodine—Dry eye—Esomeprazole—Barrett's esophagus	0.00462	0.014	CcSEcCtD
Fesoterodine—Dry eye—Omeprazole—Barrett's esophagus	0.00462	0.014	CcSEcCtD
Fesoterodine—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00409	0.0125	CcSEcCtD
Fesoterodine—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00409	0.0125	CcSEcCtD
Fesoterodine—Face oedema—Esomeprazole—Barrett's esophagus	0.0035	0.0107	CcSEcCtD
Fesoterodine—Face oedema—Omeprazole—Barrett's esophagus	0.0035	0.0107	CcSEcCtD
Fesoterodine—Dry skin—Esomeprazole—Barrett's esophagus	0.00333	0.0101	CcSEcCtD
Fesoterodine—Dry skin—Omeprazole—Barrett's esophagus	0.00333	0.0101	CcSEcCtD
Fesoterodine—Abdominal pain upper—Esomeprazole—Barrett's esophagus	0.00331	0.0101	CcSEcCtD
Fesoterodine—Abdominal pain upper—Omeprazole—Barrett's esophagus	0.00331	0.0101	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.0032	0.00974	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.0032	0.00974	CcSEcCtD
Fesoterodine—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00305	0.00929	CcSEcCtD
Fesoterodine—Angina pectoris—Omeprazole—Barrett's esophagus	0.00305	0.00929	CcSEcCtD
Fesoterodine—Dysuria—Esomeprazole—Barrett's esophagus	0.00293	0.00892	CcSEcCtD
Fesoterodine—Dysuria—Omeprazole—Barrett's esophagus	0.00293	0.00892	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00291	0.00887	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00291	0.00887	CcSEcCtD
Fesoterodine—Infestation NOS—Omeprazole—Barrett's esophagus	0.0028	0.00851	CcSEcCtD
Fesoterodine—Infestation—Omeprazole—Barrett's esophagus	0.0028	0.00851	CcSEcCtD
Fesoterodine—Infestation—Esomeprazole—Barrett's esophagus	0.0028	0.00851	CcSEcCtD
Fesoterodine—Infestation NOS—Esomeprazole—Barrett's esophagus	0.0028	0.00851	CcSEcCtD
Fesoterodine—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00272	0.00827	CcSEcCtD
Fesoterodine—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00272	0.00827	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00264	0.00805	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00264	0.00805	CcSEcCtD
Fesoterodine—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00248	0.00754	CcSEcCtD
Fesoterodine—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00248	0.00754	CcSEcCtD
Fesoterodine—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00247	0.00752	CcSEcCtD
Fesoterodine—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00247	0.00752	CcSEcCtD
Fesoterodine—Urethral disorder—Omeprazole—Barrett's esophagus	0.00246	0.00749	CcSEcCtD
Fesoterodine—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00246	0.00749	CcSEcCtD
Fesoterodine—Eye disorder—Esomeprazole—Barrett's esophagus	0.00235	0.00714	CcSEcCtD
Fesoterodine—Eye disorder—Omeprazole—Barrett's esophagus	0.00235	0.00714	CcSEcCtD
Fesoterodine—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00226	0.00688	CcSEcCtD
Fesoterodine—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00226	0.00688	CcSEcCtD
Fesoterodine—Mental disorder—Esomeprazole—Barrett's esophagus	0.0022	0.00669	CcSEcCtD
Fesoterodine—Mental disorder—Omeprazole—Barrett's esophagus	0.0022	0.00669	CcSEcCtD
Fesoterodine—Flatulence—Esomeprazole—Barrett's esophagus	0.00215	0.00655	CcSEcCtD
Fesoterodine—Flatulence—Omeprazole—Barrett's esophagus	0.00215	0.00655	CcSEcCtD
Fesoterodine—Dysgeusia—Esomeprazole—Barrett's esophagus	0.00214	0.00651	CcSEcCtD
Fesoterodine—Dysgeusia—Omeprazole—Barrett's esophagus	0.00214	0.00651	CcSEcCtD
Fesoterodine—Back pain—Esomeprazole—Barrett's esophagus	0.00211	0.00643	CcSEcCtD
Fesoterodine—Back pain—Omeprazole—Barrett's esophagus	0.00211	0.00643	CcSEcCtD
Fesoterodine—Vision blurred—Omeprazole—Barrett's esophagus	0.00206	0.00627	CcSEcCtD
Fesoterodine—Vision blurred—Esomeprazole—Barrett's esophagus	0.00206	0.00627	CcSEcCtD
Fesoterodine—Angioedema—Esomeprazole—Barrett's esophagus	0.002	0.00607	CcSEcCtD
Fesoterodine—Angioedema—Omeprazole—Barrett's esophagus	0.002	0.00607	CcSEcCtD
Fesoterodine—Vertigo—Omeprazole—Barrett's esophagus	0.00196	0.00597	CcSEcCtD
Fesoterodine—Vertigo—Esomeprazole—Barrett's esophagus	0.00196	0.00597	CcSEcCtD
Fesoterodine—Palpitations—Esomeprazole—Barrett's esophagus	0.00193	0.00587	CcSEcCtD
Fesoterodine—Palpitations—Omeprazole—Barrett's esophagus	0.00193	0.00587	CcSEcCtD
Fesoterodine—Cough—Omeprazole—Barrett's esophagus	0.00191	0.0058	CcSEcCtD
Fesoterodine—Cough—Esomeprazole—Barrett's esophagus	0.00191	0.0058	CcSEcCtD
Fesoterodine—Chest pain—Esomeprazole—Barrett's esophagus	0.00186	0.00566	CcSEcCtD
Fesoterodine—Chest pain—Omeprazole—Barrett's esophagus	0.00186	0.00566	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00185	0.00562	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00185	0.00562	CcSEcCtD
Fesoterodine—Dry mouth—Omeprazole—Barrett's esophagus	0.00182	0.00554	CcSEcCtD
Fesoterodine—Dry mouth—Esomeprazole—Barrett's esophagus	0.00182	0.00554	CcSEcCtD
Fesoterodine—Confusional state—Esomeprazole—Barrett's esophagus	0.0018	0.00547	CcSEcCtD
Fesoterodine—Confusional state—Omeprazole—Barrett's esophagus	0.0018	0.00547	CcSEcCtD
Fesoterodine—Infection—Esomeprazole—Barrett's esophagus	0.00177	0.00539	CcSEcCtD
Fesoterodine—Infection—Omeprazole—Barrett's esophagus	0.00177	0.00539	CcSEcCtD
Fesoterodine—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00175	0.00532	CcSEcCtD
Fesoterodine—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00175	0.00532	CcSEcCtD
Fesoterodine—Tachycardia—Omeprazole—Barrett's esophagus	0.00174	0.0053	CcSEcCtD
Fesoterodine—Tachycardia—Esomeprazole—Barrett's esophagus	0.00174	0.0053	CcSEcCtD
Fesoterodine—Skin disorder—Esomeprazole—Barrett's esophagus	0.00173	0.00527	CcSEcCtD
Fesoterodine—Skin disorder—Omeprazole—Barrett's esophagus	0.00173	0.00527	CcSEcCtD
Fesoterodine—Insomnia—Omeprazole—Barrett's esophagus	0.00161	0.00491	CcSEcCtD
Fesoterodine—Insomnia—Esomeprazole—Barrett's esophagus	0.00161	0.00491	CcSEcCtD
Fesoterodine—Somnolence—Omeprazole—Barrett's esophagus	0.00159	0.00482	CcSEcCtD
Fesoterodine—Somnolence—Esomeprazole—Barrett's esophagus	0.00159	0.00482	CcSEcCtD
Fesoterodine—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00157	0.00478	CcSEcCtD
Fesoterodine—Dyspepsia—Omeprazole—Barrett's esophagus	0.00157	0.00478	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00154	0.00468	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00154	0.00468	CcSEcCtD
Fesoterodine—Fatigue—Esomeprazole—Barrett's esophagus	0.00154	0.00468	CcSEcCtD
Fesoterodine—Fatigue—Omeprazole—Barrett's esophagus	0.00154	0.00468	CcSEcCtD
Fesoterodine—Constipation—Omeprazole—Barrett's esophagus	0.00153	0.00464	CcSEcCtD
Fesoterodine—Constipation—Esomeprazole—Barrett's esophagus	0.00153	0.00464	CcSEcCtD
Fesoterodine—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00147	0.00447	CcSEcCtD
Fesoterodine—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00147	0.00447	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00146	0.00444	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00146	0.00444	CcSEcCtD
Fesoterodine—Urticaria—Esomeprazole—Barrett's esophagus	0.00142	0.00431	CcSEcCtD
Fesoterodine—Urticaria—Omeprazole—Barrett's esophagus	0.00142	0.00431	CcSEcCtD
Fesoterodine—Abdominal pain—Omeprazole—Barrett's esophagus	0.00141	0.00429	CcSEcCtD
Fesoterodine—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00141	0.00429	CcSEcCtD
Fesoterodine—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00131	0.004	CcSEcCtD
Fesoterodine—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00131	0.004	CcSEcCtD
Fesoterodine—Asthenia—Omeprazole—Barrett's esophagus	0.00128	0.00389	CcSEcCtD
Fesoterodine—Asthenia—Esomeprazole—Barrett's esophagus	0.00128	0.00389	CcSEcCtD
Fesoterodine—Pruritus—Esomeprazole—Barrett's esophagus	0.00126	0.00384	CcSEcCtD
Fesoterodine—Pruritus—Omeprazole—Barrett's esophagus	0.00126	0.00384	CcSEcCtD
Fesoterodine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00124	0.0423	CbGpPWpGaD
Fesoterodine—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00122	0.00371	CcSEcCtD
Fesoterodine—Diarrhoea—Omeprazole—Barrett's esophagus	0.00122	0.00371	CcSEcCtD
Fesoterodine—Dizziness—Esomeprazole—Barrett's esophagus	0.00118	0.00359	CcSEcCtD
Fesoterodine—Dizziness—Omeprazole—Barrett's esophagus	0.00118	0.00359	CcSEcCtD
Fesoterodine—Rash—Esomeprazole—Barrett's esophagus	0.00112	0.00342	CcSEcCtD
Fesoterodine—Rash—Omeprazole—Barrett's esophagus	0.00112	0.00342	CcSEcCtD
Fesoterodine—Dermatitis—Omeprazole—Barrett's esophagus	0.00112	0.00342	CcSEcCtD
Fesoterodine—Dermatitis—Esomeprazole—Barrett's esophagus	0.00112	0.00342	CcSEcCtD
Fesoterodine—Headache—Omeprazole—Barrett's esophagus	0.00112	0.0034	CcSEcCtD
Fesoterodine—Headache—Esomeprazole—Barrett's esophagus	0.00112	0.0034	CcSEcCtD
Fesoterodine—Nausea—Omeprazole—Barrett's esophagus	0.00106	0.00322	CcSEcCtD
Fesoterodine—Nausea—Esomeprazole—Barrett's esophagus	0.00106	0.00322	CcSEcCtD
Fesoterodine—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000765	0.0261	CbGpPWpGaD
Fesoterodine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000713	0.0243	CbGpPWpGaD
Fesoterodine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000713	0.0243	CbGpPWpGaD
Fesoterodine—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000459	0.0156	CbGpPWpGaD
Fesoterodine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000439	0.015	CbGpPWpGaD
Fesoterodine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000439	0.015	CbGpPWpGaD
Fesoterodine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000427	0.0145	CbGpPWpGaD
Fesoterodine—CYP2D6—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000421	0.0143	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—CRTC1—Barrett's esophagus	0.000393	0.0134	CbGpPWpGaD
Fesoterodine—CHRM5—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000385	0.0131	CbGpPWpGaD
Fesoterodine—CHRM4—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.00037	0.0126	CbGpPWpGaD
Fesoterodine—CHRM5—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000354	0.0121	CbGpPWpGaD
Fesoterodine—CYP2D6—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000346	0.0118	CbGpPWpGaD
Fesoterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000344	0.0117	CbGpPWpGaD
Fesoterodine—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000305	0.0104	CbGpPWpGaD
Fesoterodine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000279	0.0095	CbGpPWpGaD
Fesoterodine—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000275	0.00938	CbGpPWpGaD
Fesoterodine—CHRM1—G alpha (q) signalling events—GAST—Barrett's esophagus	0.000271	0.00923	CbGpPWpGaD
Fesoterodine—CHRM3—G alpha (q) signalling events—GAST—Barrett's esophagus	0.00027	0.0092	CbGpPWpGaD
Fesoterodine—CHRM1—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000249	0.00849	CbGpPWpGaD
Fesoterodine—CHRM3—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000248	0.00846	CbGpPWpGaD
Fesoterodine—CHRM2—Regulation of Actin Cytoskeleton—SLC9A1—Barrett's esophagus	0.000246	0.00838	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000242	0.00826	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000242	0.00823	CbGpPWpGaD
Fesoterodine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000235	0.00799	CbGpPWpGaD
Fesoterodine—CHRM4—G alpha (i) signalling events—SST—Barrett's esophagus	0.000229	0.00782	CbGpPWpGaD
Fesoterodine—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000226	0.0077	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000212	0.00722	CbGpPWpGaD
Fesoterodine—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	0.000184	0.00626	CbGpPWpGaD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000182	0.00621	CbGpPWpGaD
Fesoterodine—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000181	0.00617	CbGpPWpGaD
Fesoterodine—CHRM4—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000175	0.00595	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000175	0.00595	CbGpPWpGaD
Fesoterodine—CHRM5—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000167	0.0057	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—SST—Barrett's esophagus	0.000153	0.0052	CbGpPWpGaD
Fesoterodine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000145	0.00492	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—SST—Barrett's esophagus	0.000139	0.00473	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—SST—Barrett's esophagus	0.000133	0.00453	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000123	0.00419	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000123	0.00418	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000121	0.00414	CbGpPWpGaD
Fesoterodine—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.00012	0.00409	CbGpPWpGaD
Fesoterodine—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000118	0.00403	CbGpPWpGaD
Fesoterodine—CHRM1—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000118	0.00401	CbGpPWpGaD
Fesoterodine—CHRM3—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000117	0.004	CbGpPWpGaD
Fesoterodine—CHRM2—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000116	0.00396	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—GAST—Barrett's esophagus	0.000115	0.0039	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—GAST—Barrett's esophagus	0.00011	0.00374	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—GAST—Barrett's esophagus	0.000104	0.00354	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—GAST—Barrett's esophagus	9.96e-05	0.00339	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—SST—Barrett's esophagus	9.37e-05	0.00319	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—SST—Barrett's esophagus	9.34e-05	0.00318	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—SST—Barrett's esophagus	9.25e-05	0.00315	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	9.12e-05	0.00311	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—PPARG—Barrett's esophagus	8.95e-05	0.00305	CbGpPWpGaD
Fesoterodine—CHRM4—G alpha (i) signalling events—CXCL8—Barrett's esophagus	8.94e-05	0.00305	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	8.37e-05	0.00285	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	8.26e-05	0.00281	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—SST—Barrett's esophagus	7.85e-05	0.00267	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—GAST—Barrett's esophagus	7.72e-05	0.00263	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—GAST—Barrett's esophagus	7.7e-05	0.00262	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—GAST—Barrett's esophagus	7.63e-05	0.0026	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—SST—Barrett's esophagus	7.52e-05	0.00256	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—SST—Barrett's esophagus	7.13e-05	0.00243	CbGpPWpGaD
Fesoterodine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	7.11e-05	0.00242	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—GAST—Barrett's esophagus	7.01e-05	0.00239	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—GAST—Barrett's esophagus	6.99e-05	0.00238	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGES—Barrett's esophagus	6.93e-05	0.00236	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—GAST—Barrett's esophagus	6.92e-05	0.00236	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—SST—Barrett's esophagus	6.83e-05	0.00233	CbGpPWpGaD
Fesoterodine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	6.81e-05	0.00232	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—GAST—Barrett's esophagus	6.15e-05	0.00209	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	6.11e-05	0.00208	CbGpPWpGaD
Fesoterodine—CHRM2—G alpha (i) signalling events—CXCL8—Barrett's esophagus	5.95e-05	0.00203	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GAST—Barrett's esophagus	5.89e-05	0.002	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR ligand binding—CXCL8—Barrett's esophagus	5.41e-05	0.00184	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—SST—Barrett's esophagus	5.29e-05	0.0018	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—SST—Barrett's esophagus	5.28e-05	0.0018	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP26A1—Barrett's esophagus	5.25e-05	0.00179	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—SST—Barrett's esophagus	5.23e-05	0.00178	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR ligand binding—CXCL8—Barrett's esophagus	5.18e-05	0.00177	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	5.13e-05	0.00175	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—SST—Barrett's esophagus	4.81e-05	0.00164	CbGpPWpGaD
Fesoterodine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.79e-05	0.00163	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—SST—Barrett's esophagus	4.79e-05	0.00163	CbGpPWpGaD
Fesoterodine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.78e-05	0.00163	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—SST—Barrett's esophagus	4.75e-05	0.00162	CbGpPWpGaD
Fesoterodine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.73e-05	0.00161	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	4.64e-05	0.00158	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGES—Barrett's esophagus	4.4e-05	0.0015	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SST—Barrett's esophagus	4.21e-05	0.00143	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—TP53—Barrett's esophagus	4.19e-05	0.00143	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGES—Barrett's esophagus	4.15e-05	0.00141	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GAST—Barrett's esophagus	4.14e-05	0.00141	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GAST—Barrett's esophagus	4.13e-05	0.00141	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GAST—Barrett's esophagus	4.09e-05	0.00139	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SST—Barrett's esophagus	4.03e-05	0.00137	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—SLC9A1—Barrett's esophagus	3.79e-05	0.00129	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR ligand binding—CXCL8—Barrett's esophagus	3.65e-05	0.00124	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR ligand binding—CXCL8—Barrett's esophagus	3.64e-05	0.00124	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR ligand binding—CXCL8—Barrett's esophagus	3.6e-05	0.00123	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	3.33e-05	0.00114	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	3.14e-05	0.00107	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—CXCL8—Barrett's esophagus	3.06e-05	0.00104	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.93e-05	0.000998	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SST—Barrett's esophagus	2.84e-05	0.000967	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SST—Barrett's esophagus	2.83e-05	0.000964	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SST—Barrett's esophagus	2.8e-05	0.000955	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—CXCL8—Barrett's esophagus	2.78e-05	0.000946	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.76e-05	0.000941	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.71e-05	0.000923	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—CXCL8—Barrett's esophagus	2.66e-05	0.000906	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.4e-05	0.000819	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	2.26e-05	0.000771	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—APC—Barrett's esophagus	2.23e-05	0.000759	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—APC—Barrett's esophagus	2.13e-05	0.000727	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.06e-05	0.000703	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.06e-05	0.0007	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	2.05e-05	0.0007	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.04e-05	0.000694	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—CXCL8—Barrett's esophagus	1.87e-05	0.000638	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—CXCL8—Barrett's esophagus	1.87e-05	0.000636	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—CXCL8—Barrett's esophagus	1.85e-05	0.00063	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—RELA—Barrett's esophagus	1.74e-05	0.000593	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PPARG—Barrett's esophagus	1.73e-05	0.000589	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—RELA—Barrett's esophagus	1.67e-05	0.000568	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CXCL8—Barrett's esophagus	1.64e-05	0.000559	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CXCL8—Barrett's esophagus	1.57e-05	0.000535	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APC—Barrett's esophagus	1.5e-05	0.000512	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APC—Barrett's esophagus	1.5e-05	0.00051	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APC—Barrett's esophagus	1.48e-05	0.000505	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.48e-05	0.000504	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PTGS2—Barrett's esophagus	1.36e-05	0.000463	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RELA—Barrett's esophagus	1.17e-05	0.0004	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RELA—Barrett's esophagus	1.17e-05	0.000399	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RELA—Barrett's esophagus	1.16e-05	0.000395	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CXCL8—Barrett's esophagus	1.11e-05	0.000377	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CXCL8—Barrett's esophagus	1.1e-05	0.000376	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PPARG—Barrett's esophagus	1.1e-05	0.000374	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CXCL8—Barrett's esophagus	1.09e-05	0.000372	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PPARG—Barrett's esophagus	1.03e-05	0.000352	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TP53—Barrett's esophagus	1.01e-05	0.000343	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TP53—Barrett's esophagus	9.64e-06	0.000328	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PTGS2—Barrett's esophagus	8.63e-06	0.000294	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	8.13e-06	0.000277	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TP53—Barrett's esophagus	6.79e-06	0.000231	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TP53—Barrett's esophagus	6.77e-06	0.000231	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PPARG—Barrett's esophagus	6.76e-06	0.00023	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TP53—Barrett's esophagus	6.7e-06	0.000228	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	5.32e-06	0.000181	CbGpPWpGaD
